Pitfalls in the molecular follow up of mutant acute myeloid leukemia.
作者信息
Bacher Ulrike, Porret Naomi, Joncourt Raphael, Sanz Javier, Aliu Nijas, Wiedemann Gertrud, Jeker Barbara, Banz Yara, Pabst Thomas
机构信息
Department of Hematology, Inselspital, Bern University Hospital, University of Bern, Switzerland.
Center of Laboratory Medicine (ZLM) Inselspital, Bern University Hospital, University of Bern, Switzerland.
出版信息
Haematologica. 2018 Oct;103(10):e486-e488. doi: 10.3324/haematol.2018.192104. Epub 2018 Jun 14.
Abstract
摘要
相似文献
1
Pitfalls in the molecular follow up of mutant acute myeloid leukemia.突变型急性髓系白血病分子随访中的陷阱
Haematologica. 2018 Oct;103(10):e486-e488. doi: 10.3324/haematol.2018.192104. Epub 2018 Jun 14.
2
Two novel NPM1 mutations in an acute myeloid leukemia patient transformed from primary myelofibrosis.一名从原发性骨髓纤维化转变而来的急性髓系白血病患者中发现两种新的NPM1突变。
Int J Lab Hematol. 2013 Feb;35(1):e1-3. doi: 10.1111/ijlh.12009. Epub 2012 Sep 17.
3
Sustained expression of nucleophosmin (NPM1) mutation at late relapse presenting as isolated myeloid sarcoma in a patient with acute myeloid leukemia.急性髓系白血病患者晚期复发时核磷蛋白（NPM1）突变持续表达，表现为孤立性髓系肉瘤。
Ann Hematol. 2007 Oct;86(10):763-5. doi: 10.1007/s00277-007-0323-5. Epub 2007 Jul 17.
4
A lineage switch from NPM1-mutant acute myeloid leukemia to acute T-cell lymphoblastic leukemia with KMT2D and ARID2 mutant.从伴有KMT2D和ARID2突变的NPM1突变型急性髓系白血病向急性T细胞淋巴细胞白血病的谱系转换。
Int J Lab Hematol. 2021 Aug;43(4):O230-O233. doi: 10.1111/ijlh.13534. Epub 2021 Apr 21.
5
Digital droplet PCR-based absolute quantification of pre-transplant NPM1 mutation burden predicts relapse in acute myeloid leukemia patients.基于数字液滴 PCR 的移植前 NPM1 突变负担绝对定量可预测急性髓系白血病患者的复发。
Ann Hematol. 2018 Oct;97(10):1757-1765. doi: 10.1007/s00277-018-3373-y. Epub 2018 May 22.
6
Rapid and highly specific screening for NPM1 mutations in acute myeloid leukemia.快速且高度特异性检测急性髓系白血病中的 NPM1 突变。
Ann Hematol. 2013 Jan;92(2):173-7. doi: 10.1007/s00277-012-1617-9. Epub 2012 Nov 17.
7
Venetoclax and arsenic showed synergistic anti-leukemia activity in vitro and in vivo for acute myeloid leukemia with the NPM1 mutation.维奈托克和砷在体外和体内对伴有NPM1突变的急性髓系白血病均显示出协同抗白血病活性。
Am J Hematol. 2020 Mar;95(3):E55-E57. doi: 10.1002/ajh.25719. Epub 2020 Jan 28.
8
DNA damage corrects the aberrant cytoplasmic localisation of nucleophosmin in NPM1 mutated acute myeloid leukaemia.DNA损伤纠正了NPM1突变的急性髓系白血病中核磷蛋白异常的细胞质定位。
Br J Haematol. 2019 Jul;186(2):343-347. doi: 10.1111/bjh.15823. Epub 2019 Mar 5.
9
Quantification of rare NPM1 mutation subtypes by digital PCR.通过数字PCR对罕见的NPM1突变亚型进行定量分析。
Br J Haematol. 2014 Dec;167(5):710-4. doi: 10.1111/bjh.13038. Epub 2014 Jul 18.
10
Multilineage dysplasia is associated with a poorer prognosis in patients with de novo acute myeloid leukemia with intermediate-risk cytogenetics and wild-type NPM1.多系发育异常与初发急性髓系白血病且具有中危细胞遗传学特征及野生型NPM1的患者预后较差相关。
Ann Hematol. 2014 Oct;93(10):1695-703. doi: 10.1007/s00277-014-2100-6. Epub 2014 May 14.
引用本文的文献
1
Protective effects for HLA-B*40:01 and C*03:04 in NPM1-mutated AML: result of a large HLA association study.HLA-B*40:01和C*03:04对NPM1突变型急性髓系白血病的保护作用：一项大型HLA关联研究的结果
Front Immunol. 2025 Jun 10;16:1571508. doi: 10.3389/fimmu.2025.1571508. eCollection 2025.
2
mutation subtype switch in acute myeloid leukemia.急性髓系白血病中的突变亚型转换
Haematologica. 2025 Aug 1;110(8):1887-1890. doi: 10.3324/haematol.2024.286916. Epub 2025 Mar 20.
3
The Role of Nucleophosmin 1 () Mutation in the Diagnosis and Management of Myeloid Neoplasms.核磷蛋白1（NPM1）突变在髓系肿瘤诊断与管理中的作用
Life (Basel). 2022 Jan 13;12(1):109. doi: 10.3390/life12010109.
4
Experiences with Next-Generation Sequencing in Relapsed Acute Myeloid Leukemia: A Patient Case Series.复发急性髓系白血病的下一代测序经验：病例系列报告
Mediterr J Hematol Infect Dis. 2020 Sep 1;12(1):e2020068. doi: 10.4084/MJHID.2020.068. eCollection 2020.
5
Clinical Utility of Next-Generation Sequencing in Acute Myeloid Leukemia.在急性髓系白血病中的下一代测序的临床实用性。
Mol Diagn Ther. 2020 Feb;24(1):1-13. doi: 10.1007/s40291-019-00443-9.
6
Molecular minimal residual disease negativity and decreased stem cell mobilization potential predict excellent outcome after autologous transplant in mutant acute myeloid leukemia.分子学微小残留病阴性和干细胞动员潜力降低预示着突变型急性髓系白血病自体移植后预后良好。
Haematologica. 2020 Jan;105(1):e9-e12. doi: 10.3324/haematol.2019.216457. Epub 2019 May 23.
7
Challenges in the introduction of next-generation sequencing (NGS) for diagnostics of myeloid malignancies into clinical routine use.将下一代测序（NGS）引入髓系恶性肿瘤的临床常规诊断中所面临的挑战。
Blood Cancer J. 2018 Nov 12;8(11):113. doi: 10.1038/s41408-018-0148-6.
8
Minimal/Measurable Residual Disease Monitoring in -Mutated Acute Myeloid Leukemia: A Clinical Viewpoint and Perspectives.伴有突变的急性髓系白血病中的微小残留病监测：临床观点和展望。
Int J Mol Sci. 2018 Nov 6;19(11):3492. doi: 10.3390/ijms19113492.
本文引用的文献
1
Molecular Minimal Residual Disease in Acute Myeloid Leukemia.急性髓系白血病的分子微小残留病。
N Engl J Med. 2018 Mar 29;378(13):1189-1199. doi: 10.1056/NEJMoa1716863.
2
Minimal Residual Disease Monitoring of Acute Myeloid Leukemia by Massively Multiplex Digital PCR in Patients with NPM1 Mutations.采用大规模多重数字PCR对NPM1突变的急性髓系白血病患者进行微小残留病监测
J Mol Diagn. 2017 Jul;19(4):537-548. doi: 10.1016/j.jmoldx.2017.03.005. Epub 2017 May 16.
3
Consolidation with autologous stem cell transplantation in first remission is safe and effective in AML patients above 65 years.对于65岁以上的急性髓系白血病患者，首次缓解期进行自体干细胞移植巩固治疗是安全有效的。
Leuk Res. 2017 Feb;53:28-34. doi: 10.1016/j.leukres.2016.12.001. Epub 2016 Dec 8.
4
Diagnosis and management of AML in adults: 2017 ELN recommendations from an international expert panel.成人急性髓系白血病的诊断与管理：2017年国际专家小组的欧洲白血病网络（ELN）建议
Blood. 2017 Jan 26;129(4):424-447. doi: 10.1182/blood-2016-08-733196. Epub 2016 Nov 28.
5
Long-term follow-up of patients with acute myeloid leukemia surviving and free of disease recurrence for at least 2 years after autologous stem cell transplantation: A report from the Acute Leukemia Working Party of the European Society for Blood and Marrow Transplantation.自体造血干细胞移植后至少 2 年无疾病复发并存活的急性髓系白血病患者的长期随访：来自欧洲血液和骨髓移植学会急性白血病工作组的报告。
Cancer. 2016 Jun 15;122(12):1880-7. doi: 10.1002/cncr.29990. Epub 2016 Mar 28.
6
Assessment of Minimal Residual Disease in Standard-Risk AML.标准风险 AML 中的微小残留病评估。
N Engl J Med. 2016 Feb 4;374(5):422-33. doi: 10.1056/NEJMoa1507471. Epub 2016 Jan 20.
7
Switch of the mutation type of the NPM1 gene in acute myeloid leukemia (AML): relapse or secondary AML?急性髓系白血病（AML）中NPM1基因突变类型的转变：复发还是继发性AML？
Blood Cancer J. 2014 Jun 27;4(6):e221. doi: 10.1038/bcj.2014.42.
8
Detection of minimal residual disease in NPM1-mutated acute myeloid leukemia by next-generation sequencing.通过下一代测序检测NPM1突变型急性髓系白血病中的微小残留病
Mod Pathol. 2014 Nov;27(11):1438-46. doi: 10.1038/modpathol.2014.57. Epub 2014 Apr 18.
9
Clonal evolution in relapsed NPM1-mutated acute myeloid leukemia.复发核仁磷酸蛋白 1 突变型急性髓系白血病中的克隆进化。
Blood. 2013 Jul 4;122(1):100-8. doi: 10.1182/blood-2013-01-479188. Epub 2013 May 23.
10
Monitoring of minimal residual disease in NPM1-mutated acute myeloid leukemia: a study from the German-Austrian acute myeloid leukemia study group.NPM1 突变型急性髓系白血病微小残留病监测：德国-奥地利急性髓系白血病研究组的一项研究。
J Clin Oncol. 2011 Jul 1;29(19):2709-16. doi: 10.1200/JCO.2011.35.0371. Epub 2011 May 9.
Zotero 插件